Aroa Biosurgery Ltd Total Assets

Latest as of September 2025: AU$95.27 Million AUD ≈ $67.41 Million USD

Aroa Biosurgery Ltd total assets. Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) holds total assets worth AU$95.27 Million AUD (≈ $67.41 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ARX company net worth for the company's overall valuation and market capitalisation.

Total Assets of Aroa Biosurgery Ltd (2001–2025)

Total assets of Aroa Biosurgery Ltd from 2001 to 2025. This chart illustrates how Aroa Biosurgery Ltd's total assets have evolved over time, based on quarterly financial data. See current stock price of Aroa Biosurgery Ltd for real-time trading data and today's change.

Aroa Biosurgery Ltd - Asset Composition Analysis

Aroa Biosurgery Ltd Total Assets Breakdown (March 2025)

Aroa Biosurgery Ltd total assets breakdown as of March 2025. Aroa Biosurgery Ltd's total assets of AU$95.27 Million consist of 62.6% current assets and 37.4% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 7.3%
Accounts Receivable AU$14.84 Million 15.0%
Inventory AU$7.52 Million 7.6%
Property, Plant & Equipment AU$21.51 Million 21.7%
Intangible Assets AU$12.33 Million 12.5%
Goodwill AU$5.03 Million 5.1%

Asset Composition Trend (2001–2025)

This chart illustrates how Aroa Biosurgery Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ARX working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Aroa Biosurgery Ltd's current assets represent 62.6% of total assets in 2025, an increase from 0.0% in 2001.
  • Cash Position: Cash and equivalents constituted 7.3% of total assets in 2025, down from 72.2% in 2001.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2001.
  • Asset Diversification: The largest asset category is property, plant & equipment at 21.7% of total assets.

Aroa Biosurgery Ltd Competitors by Total Assets

Key competitors of Aroa Biosurgery Ltd based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
Double Medical Technology Inc
SHE:002901
China CN¥5.03 Billion
BMC Medical Co. Ltd. A
SHE:301367
China CN¥3.59 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million
Emvision Medical Devices Ltd
AU:EMV
Australia AU$24.94 Million
Sequana Medical NV
BR:SEQUA
Belgium €14.57 Million
Hironic Co. Ltd
KQ:149980
Korea ₩80.01 Billion
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

Aroa Biosurgery Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 6.52 8.53 12.48
Quick Ratio 5.74 7.31 11.48
Cash Ratio 0.00 0.00 0.00
Working Capital AU$50.46 Million AU$51.90 Million AU$43.17 Million

Aroa Biosurgery Ltd - Advanced Valuation Insights

This section examines the relationship between Aroa Biosurgery Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.74
Latest Market Cap to Assets Ratio 1.22
Asset Growth Rate (YoY) -2.9%
Total Assets AU$98.94 Million
Market Capitalization $120.22 Million USD

Valuation Analysis

Above Book Valuation: The market values Aroa Biosurgery Ltd's assets above their book value (1.22x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: Aroa Biosurgery Ltd's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Aroa Biosurgery Ltd (2001–2025)

The table below shows the annual total assets of Aroa Biosurgery Ltd from 2001 to 2025.

Year Total Assets Change
2025-03-31 AU$98.94 Million
≈ $70.01 Million
-2.89%
2024-03-31 AU$101.88 Million
≈ $72.09 Million
-6.60%
2023-03-31 AU$109.07 Million
≈ $77.17 Million
+4.17%
2022-03-31 AU$104.71 Million
≈ $74.09 Million
+43.19%
2021-03-31 AU$73.12 Million
≈ $51.74 Million
-11.40%
2020-03-31 AU$82.54 Million
≈ $58.40 Million
+117.42%
2019-03-31 AU$37.96 Million
≈ $26.86 Million
+165.41%
2018-03-31 AU$14.30 Million
≈ $10.12 Million
+119.53%
2017-03-31 AU$6.52 Million
≈ $4.61 Million
+2.51%
2016-03-31 AU$6.36 Million
≈ $4.50 Million
-15.37%
2015-03-31 AU$7.51 Million
≈ $5.31 Million
-10.66%
2014-03-31 AU$8.41 Million
≈ $5.95 Million
-10.16%
2013-03-31 AU$9.36 Million
≈ $6.62 Million
-14.38%
2012-03-31 AU$10.93 Million
≈ $7.73 Million
+35.33%
2011-03-31 AU$8.07 Million
≈ $5.71 Million
+57.38%
2010-03-31 AU$5.13 Million
≈ $3.63 Million
-93.82%
2009-03-31 AU$83.08 Million
≈ $58.79 Million
+16.03%
2008-03-31 AU$71.60 Million
≈ $50.66 Million
-19.12%
2007-03-31 AU$88.53 Million
≈ $62.64 Million
+118.18%
2006-03-31 AU$40.58 Million
≈ $28.71 Million
+107.03%
2005-03-31 AU$19.60 Million
≈ $13.87 Million
+26.93%
2004-03-31 AU$15.44 Million
≈ $10.93 Million
+27.39%
2003-03-31 AU$12.12 Million
≈ $8.58 Million
-1.97%
2002-03-31 AU$12.37 Million
≈ $8.75 Million
-10.73%
2001-03-31 AU$13.85 Million
≈ $9.80 Million
--

About Aroa Biosurgery Ltd

AU:ARX Australia Medical Devices
Market Cap
$120.22 Million
AU$169.91 Million AUD
Market Cap Rank
#18290 Global
#557 in Australia
Share Price
AU$0.49
Change (1 day)
+1.03%
52-Week Range
AU$0.49 - AU$0.79
All Time High
AU$1.54
About

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more